Balance Sheet Amgen Inc.

Equities

AMGN

US0311621009

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-13 pm EST			5-day change	1st Jan Change
369.19 ^USD	+1.52%		-3.94%	+12.80%

Feb. 12	Amgen Inc. Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium, Feb-12-2026 05:00 PM
Feb. 12	European Commission approves Amgen's Uplizna® for generalized myasthenia gravis	RE

04199f.pYsmB6KCbYnZ5DkyJlHt9rx8ukEHhYXQKcbFi_qt2BM.6cRoavHnDMGYnE1DTimhxdkK_yRe98voRred-cLdkkfB_2BQ5Mwc5a_QbA

Published financial data: AMGEN INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	24.24B	24.3B	24.8B	26.91B	32.03B
Other Revenues, Total	1.18B	1.68B	1.52B	1.28B	1.4B
Total Revenues	25.42B	25.98B	26.32B	28.19B	33.42B
Cost of Goods Sold, Total	6.16B	6.45B	6.41B	8.42B	10.46B
Gross Profit	19.26B	19.52B	19.92B	19.78B	22.97B
Selling General & Admin Expenses, Total	5.73B	5.37B	5.41B	6.17B	7.1B
R&D Expenses	4.21B	4.82B	4.43B	4.76B	5.96B
Other Operating Expenses	-	-	-	855M	230M
Other Operating Expenses, Total	9.94B	10.19B	9.85B	11.78B	13.29B
Operating Income	9.33B	9.34B	10.07B	8B	9.68B
Interest Expense, Total	-1.04B	-1.2B	-1.41B	-4.08B	-3.66B
Interest And Investment Income	-	-	-	1.2B	510M
Net Interest Expenses	-1.04B	-1.2B	-1.41B	-2.88B	-3.16B
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	323M	-245M	-233M	42M	-75M
Other Non Operating Income (Expenses)	-324M	978M	-180M	1.13B	512M
EBT, Excl. Unusual Items	8.29B	8.87B	8.25B	6.29B	6.96B
Restructuring Charges	-	-194M	-	-267M	-
Merger & Related Restructuring Charges	-	-	-	-	-2.4B
Gain (Loss) On Sale Of Investments	33M	-474M	-479M	1.44B	-146M
Gain (Loss) On Sale Of Assets	-	-	-503M	-	-
Asset Writedown	-	-	-	-	-
In Process R&D Expenses	-	-1.5B	-	-	-
Legal Settlements	-189M	-	-	-	-
Other Unusual Items	-	-	78M	390M	197M
EBT, Incl. Unusual Items	8.13B	6.7B	7.35B	7.86B	4.61B
Income Tax Expense	869M	808M	794M	1.14B	519M
Earnings From Continuing Operations	7.26B	5.89B	6.55B	6.72B	4.09B
Net Income to Company	7.26B	5.89B	6.55B	6.72B	4.09B
Net Income - (IS)	7.26B	5.89B	6.55B	6.72B	4.09B
Net Income to Common Incl Extra Items	7.26B	5.89B	6.55B	6.72B	4.09B
Net Income to Common Excl. Extra Items	7.26B	5.89B	6.55B	6.72B	4.09B
Per Share Items
Net EPS - Basic	12.4	10.34	12.18	12.56	7.62
Basic EPS - Continuing Operations	12.4	10.34	12.18	12.56	7.62
Basic Weighted Average Shares Outstanding	586M	570M	538M	535M	537M
Net EPS - Diluted	12.31	10.28	12.11	12.49	7.56
Diluted EPS - Continuing Operations	12.31	10.28	12.11	12.49	7.56
Diluted Weighted Average Shares Outstanding	590M	573M	541M	538M	541M
Normalized Basic EPS	8.84	9.73	9.58	7.35	8.1
Normalized Diluted EPS	8.78	9.68	9.53	7.31	8.04
Dividend Per Share	6.4	7.04	7.76	8.52	9
Payout Ratio	51.69	68.1	64.04	67.83	118.14
American Depositary Receipts Ratio (ADR)	0.04	0.04	0.04	0.04	0.04
Supplemental Items
EBITDA	12.77B	12.58B	13.49B	12.07B	15.16B
EBITA	12.13B	11.94B	12.67B	11.2B	14.48B
EBIT	9.33B	9.34B	10.07B	8B	9.68B
EBITDAR	12.96B	12.78B	13.67B	12.25B	15.36B
Total Revenues (As Reported)	25.42B	25.98B	26.32B	28.19B	33.42B
Effective Tax Rate - (Ratio)	10.68	12.06	10.81	14.49	11.26
Current Domestic Taxes	955M	883M	1.76B	1.57B	998M
Current Foreign Taxes	277M	359M	304M	786M	759M
Total Current Taxes	1.23B	1.24B	2.07B	2.35B	1.76B
Deferred Domestic Taxes	-312M	-317M	-1.21B	-1.15B	-878M
Deferred Foreign Taxes	-51M	-117M	-63M	-66M	-360M
Total Deferred Taxes	-363M	-434M	-1.28B	-1.22B	-1.24B
Normalized Net Income	5.18B	5.55B	5.16B	3.93B	4.35B
Interest on Long-Term Debt	1.26B	-	-	-	-
Supplemental Operating Expense Items
Advertising Expense	962M	843M	841M	647M	987M
Selling and Marketing Expenses	962M	843M	841M	647M	987M
Research And Development Expense From Footnotes	4.21B	6.32B	4.43B	4.78B	5.96B
Net Rental Expense, Total	189M	199M	186M	180M	202M
Imputed Operating Lease Interest Expense	49.14M	56.53M	56.84M	112M	93.78M
Imputed Operating Lease Depreciation	140M	142M	129M	68.3M	108M
Stock-Based Comp., Other (Total)	330M	341M	401M	473M	530M
Total Stock-Based Compensation	330M	341M	401M	473M	530M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	6.27B	7.99B	7.63B	10.94B	11.97B
Short Term Investments	4.38B	48M	1.68B	-	-
Total Cash And Short Term Investments	10.65B	8.04B	9.3B	10.94B	11.97B
Accounts Receivable, Total	4.52B	4.9B	5.56B	7.27B	6.78B
Other Receivables	799M	944M	829M	674M	719M
Total Receivables	5.32B	5.84B	6.39B	7.94B	7.5B
Inventory	3.89B	4.09B	4.93B	9.52B	7B
Prepaid Expenses	1.16B	1.22B	1.2B	1.65B	2.14B
Other Current Assets, Total	124M	200M	355M	281M	419M
Total Current Assets	21.14B	19.38B	22.19B	30.33B	29.03B
Gross Property Plant And Equipment	14.27B	14.55B	15.29B	16.4B	17.49B
Accumulated Depreciation	-8.98B	-8.8B	-9.28B	-9.81B	-10.39B
Net Property Plant And Equipment	5.3B	5.75B	6.01B	6.59B	7.1B
Long-term Investments	1.18B	4.5B	3.16B	4.45B	4.77B
Goodwill	14.69B	14.89B	15.53B	18.63B	18.64B
Other Intangibles, Total	16.59B	15.18B	16.08B	32.64B	27.7B
Other Long-Term Assets, Total	4.06B	1.46B	2.16B	4.51B	4.6B
Total Assets	62.95B	61.16B	65.12B	97.15B	91.84B
Liabilities
Accounts Payable, Total	1.42B	1.37B	1.57B	1.59B	1.91B
Accrued Expenses, Total	7.67B	8.26B	9.49B	12.37B	13.67B
Current Portion of Long-Term Debt	91M	87M	1.59B	1.44B	3.55B
Current Portion of Leases	153M	145M	156M	119M	107M
Current Income Taxes Payable	828M	701M	1.2B	1.66B	2.58B
Other Current Liabilities	1.49B	1.62B	1.68B	1.2B	1.28B
Total Current Liabilities	11.65B	12.18B	15.69B	18.39B	23.1B
Long-Term Debt	32.9B	33.22B	37.35B	63.17B	56.55B
Long-Term Leases	306M	525M	539M	691M	673M
Deferred Tax Liability Non Current	-	-	-	2.35B	1.62B
Other Non Current Liabilities	8.68B	8.53B	7.88B	6.32B	4.02B
Total Liabilities	53.54B	54.46B	61.46B	90.92B	85.96B
Common Stock, Total	31.8B	32.1B	32.51B	33.07B	33.53B
Retained Earnings	-21.41B	-24.6B	-28.62B	-26.55B	-27.59B
Comprehensive Income and Other	-985M	-796M	-231M	-289M	-66M
Total Common Equity	9.41B	6.7B	3.66B	6.23B	5.88B
Total Equity	9.41B	6.7B	3.66B	6.23B	5.88B
Total Liabilities And Equity	62.95B	61.16B	65.12B	97.15B	91.84B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	578M	557M	534M	536M	537M
ECS Total Common Shares Outstanding	578M	558M	534M	535M	537M
Book Value / Share	16.27	12	6.86	11.64	10.95
Tangible Book Value	-21.87B	-23.37B	-27.95B	-45.04B	-40.46B
Tangible Book Value Per Share	-37.81	-41.86	-52.34	-84.12	-75.36
Total Debt	33.44B	33.98B	39.64B	65.42B	60.88B
Net Debt	22.8B	25.94B	30.34B	54.48B	48.91B
Debt Equivalent Oper. Leases	1.51B	1.59B	1.49B	1.44B	1.62B
Equity Method Investments, Total	496M	3.63B	2.45B	251M	637M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	486M	647M	828M	993M	818M
Inventories - Work In Process, Total	2.44B	2.37B	3.1B	5.75B	4.12B
Inventories - Finished Goods, Total	970M	1.07B	1B	2.78B	2.06B
Land - (BS)	259M	279M	292M	339M	346M
Buildings, Total	3.86B	4.03B	4.2B	4.51B	4.8B
Machinery, Total	6.53B	6.68B	6.86B	7.09B	7.23B
Full Time Employees	24.3K	24.2K	25.2K	26.7K	28K
Accumulated Allowance for Doubtful Accounts (Supple)	32M	26M	22M	28M	38M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	7.26B	5.89B	6.55B	6.72B	4.09B
Depreciation & Amortization - CF	640M	644M	817M	871M	792M
Amortization of Goodwill and Intangible Assets - (CF)	2.8B	2.6B	2.6B	3.2B	4.8B
Depreciation & Amortization, Total	3.44B	3.24B	3.42B	4.07B	5.59B
(Gain) Loss From Sale Of Asset	-	-	567M	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	891M	-1.55B	149M
Asset Writedown & Restructuring Costs	-	1.5B	-	-	-
Stock-Based Compensation (CF)	330M	341M	401M	431M	530M
Other Operating Activities, Total	-321M	-528M	-1.37B	-710M	-1.24B
Change In Accounts Receivable	-427M	-429M	-746M	-1.02B	441M
Change In Inventories	-215M	-165M	-742M	491M	2.53B
Change In Accounts Payable	45M	-69M	154M	-402M	312M
Change In Income Taxes	-731M	-650M	-418M	-660M	-1.5B
Change in Other Net Operating Assets	1.11B	119M	1.02B	1.1B	583M
Cash from Operations	10.5B	9.26B	9.72B	8.47B	11.49B
Capital Expenditure	-608M	-880M	-936M	-1.11B	-1.1B
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-2.53B	-3.84B	-26.99B	-
Divestitures	-	-	130M	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-4.72B	4.18B	-1.39B	1.67B	-
Other Investing Activities, Total	-75M	-35M	-12M	225M	50M
Cash from Investing	-5.4B	733M	-6.04B	-26.2B	-1.05B
Long-Term Debt Issued, Total	8.91B	4.94B	6.92B	27.78B	-
Total Debt Issued	8.91B	4.94B	6.92B	27.78B	-
Long-Term Debt Repaid, Total	-6.45B	-4.15B	-297M	-2.1B	-4.26B
Total Debt Repaid	-6.45B	-4.15B	-297M	-2.1B	-4.26B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-3.49B	-4.98B	-6.36B	-	-200M
Common Dividends Paid	-3.76B	-4.01B	-4.2B	-4.56B	-4.83B
Common & Preferred Stock Dividends Paid	-3.76B	-4.01B	-4.2B	-4.56B	-4.83B
Other Financing Activities, Total	-90M	-78M	-103M	-72M	-124M
Cash from Financing	-4.87B	-8.27B	-4.04B	21.05B	-9.42B
Net Change in Cash	229M	1.72B	-360M	3.32B	1.03B
Supplemental Items
Cash Interest Paid	1.2B	1.2B	1.2B	2.4B	3.3B
Cash Income Tax Paid (Refund)	1.4B	1.9B	2.4B	3.4B	2.9B
Levered Free Cash Flow	9.04B	7.49B	8.75B	2.27B	13.73B
Unlevered Free Cash Flow	9.69B	8.23B	9.63B	4.81B	16.02B
Change In Net Working Capital	-699M	308M	-455M	3.62B	-4.94B
Net Debt Issued / Repaid	2.46B	795M	6.62B	25.68B	-4.26B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	9.51	9.4	9.97	6.16	6.4
Return on Total Capital	14.06	13.97	14.99	8.7	8.74
Return On Equity %	76.13	73.16	126.47	135.79	67.55
Return on Common Equity	76.13	73.16	126.47	135.79	67.55
Margin Analysis
Gross Profit Margin %	75.77	75.16	75.66	70.15	68.71
SG&A Margin	22.54	20.66	20.57	21.87	21.23
EBITDA Margin %	50.22	48.43	51.23	42.82	45.35
EBITA Margin %	47.7	45.95	48.13	39.73	43.31
EBIT Margin %	36.69	35.94	38.25	28.38	28.95
Income From Continuing Operations Margin %	28.57	22.68	24.89	23.83	12.24
Net Income Margin %	28.57	22.68	24.89	23.83	12.24
Net Avail. For Common Margin %	28.57	22.68	24.89	23.83	12.24
Normalized Net Income Margin	20.38	21.35	19.59	13.95	13.01
Levered Free Cash Flow Margin	35.57	28.81	33.25	8.04	41.07
Unlevered Free Cash Flow Margin	38.12	31.69	36.58	17.08	47.92
Asset Turnover
Asset Turnover	0.41	0.42	0.42	0.35	0.35
Fixed Assets Turnover	4.75	4.7	4.48	4.48	4.88
Receivables Turnover (Average Receivables)	5.65	5.16	4.74	4.19	4.56
Inventory Turnover (Average Inventory)	1.65	1.62	1.42	1.16	1.27
Short Term Liquidity
Current Ratio	1.81	1.59	1.41	1.65	1.26
Quick Ratio	1.37	1.14	1	1.03	0.84
Operating Cash Flow to Current Liabilities	0.9	0.76	0.62	0.46	0.5
Days Sales Outstanding (Average Receivables)	64.79	70.76	76.96	87.02	80.28
Days Outstanding Inventory (Average Inventory)	222.16	225.62	256.86	313.34	289.01
Average Days Payable Outstanding	78.99	76.52	73.96	44.38	80.64
Cash Conversion Cycle (Average Days)	207.96	219.86	259.86	355.98	288.65
Long Term Solvency
Total Debt/Equity	355.46	507.15	1.08K	1.05K	1.04K
Total Debt / Total Capital	78.04	83.53	91.55	91.3	91.2
LT Debt/Equity	352.86	503.69	1.04K	1.02K	973.66
Long-Term Debt / Total Capital	77.47	82.96	87.51	89.12	85.72
Total Liabilities / Total Assets	85.05	89.05	94.38	93.59	93.6
EBIT / Interest Expense	8.99	7.8	7.16	1.96	2.64
EBITDA / Interest Expense	12.48	10.68	9.72	3.01	4.19
(EBITDA - Capex) / Interest Expense	11.9	9.94	9.06	2.73	3.89
Total Debt / EBITDA	2.58	2.66	2.9	5.34	3.96
Net Debt / EBITDA	1.76	2.03	2.22	4.45	3.18
Total Debt / (EBITDA - Capex)	2.71	2.86	3.11	5.87	4.27
Net Debt / (EBITDA - Capex)	1.85	2.18	2.38	4.89	3.43
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.83	2.18	1.32	7.09	18.57
Gross Profit, 1 Yr. Growth %	1.36	1.35	2.01	-0.71	12.61
EBITDA, 1 Yr. Growth %	8.61	-1.46	5.89	-10.07	11.53
EBITA, 1 Yr. Growth %	9.05	-1.57	6.12	-11.15	12.58
EBIT, 1 Yr. Growth %	-4.04	0.11	7.83	-20.04	0.19
Earnings From Cont. Operations, 1 Yr. Growth %	-7.37	-18.87	11.18	2.52	-39.11
Net Income, 1 Yr. Growth %	-7.37	-18.87	11.18	2.52	-39.11
Normalized Net Income, 1 Yr. Growth %	-9.2	3.34	-7.03	-23.1	-12.51
Diluted EPS Before Extra, 1 Yr. Growth %	-4.43	-16.49	17.8	3.14	-39.47
Accounts Receivable, 1 Yr. Growth %	11.54	8.18	13.65	30.65	-6.69
Inventory, 1 Yr. Growth %	8.62	4.96	20.66	93.06	-26.48
Net Property, Plant and Equip., 1 Yr. Growth %	-1.85	8.55	4.45	9.76	7.71
Total Assets, 1 Yr. Growth %	5.43	-2.83	6.47	49.19	-5.47
Tangible Book Value, 1 Yr. Growth %	-10.54	6.88	19.58	61.15	-10.17
Common Equity, 1 Yr. Growth %	-2.73	-28.79	-45.36	70.23	-5.7
Cash From Operations, 1 Yr. Growth %	14.72	-11.77	4.97	-12.86	35.64
Capital Expenditures, 1 Yr. Growth %	-1.62	44.74	6.36	18.8	-1.44
Levered Free Cash Flow, 1 Yr. Growth %	40.12	-17.22	14.56	-73.73	315.38
Unlevered Free Cash Flow, 1 Yr. Growth %	33.51	-15.04	14.82	-49.8	173.73
Dividend Per Share, 1 Yr. Growth %	10.34	10	10.23	9.79	5.63
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.47	5.45	1.75	4.17	12.68
Gross Profit, 2 Yr. CAGR %	-0.97	1.36	1.68	0.64	7.3
EBITDA, 2 Yr. CAGR %	1.14	3.37	2.13	-1.93	6.52
EBITA, 2 Yr. CAGR %	1.16	3.52	2.21	-2.38	6.77
EBIT, 2 Yr. CAGR %	-5.97	-2.09	3.9	-6.51	-2.11
Earnings From Cont. Operations, 2 Yr. CAGR %	-6.97	-13.31	-5.03	6.76	-20.99
Net Income, 2 Yr. CAGR %	-6.97	-13.31	-5.03	6.76	-20.99
Normalized Net Income, 2 Yr. CAGR %	-9.49	-1.51	-2.21	-14.88	-8.32
Diluted EPS Before Extra, 2 Yr. CAGR %	-1.24	-10.66	-0.82	10.23	-20.99
Accounts Receivable, 2 Yr. CAGR %	12.43	9.84	10.88	21.85	10.41
Inventory, 2 Yr. CAGR %	15.07	6.77	12.53	52.62	19.14
Net Property, Plant and Equip., 2 Yr. CAGR %	3.36	3.22	6.48	7.07	8.73
Total Assets, 2 Yr. CAGR %	-2.65	1.21	1.71	26.03	18.76
Tangible Book Value, 2 Yr. CAGR %	50.6	-2.22	13.05	38.82	20.32
Common Equity, 2 Yr. CAGR %	-13.24	-16.77	-37.62	-3.56	26.7
Cash From Operations, 2 Yr. CAGR %	-3.6	0.6	-3.77	-4.36	8.72
Capital Expenditures, 2 Yr. CAGR %	-9.23	19.33	24.08	12.41	8.21
Levered Free Cash Flow, 2 Yr. CAGR %	6.9	7.6	-2.62	-45.07	25.68
Unlevered Free Cash Flow, 2 Yr. CAGR %	5.05	6.42	-1.13	-23.7	28.84
Dividend Per Share, 2 Yr. CAGR %	10.1	10.17	10.11	10.01	7.69
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.62	3.04	4.06	3.5	8.76
Gross Profit, 3 Yr. CAGR %	0.85	-0.21	1.57	0.87	5.56
EBITDA, 3 Yr. CAGR %	1.41	0.27	4.63	-2.27	6.5
EBITA, 3 Yr. CAGR %	1.38	0.24	4.38	-2.62	7.2
EBIT, 3 Yr. CAGR %	-3.38	-3.99	1.11	-4.99	1.88
Earnings From Cont. Operations, 3 Yr. CAGR %	54.26	-11.12	-5.81	-2.58	-11.46
Net Income, 3 Yr. CAGR %	54.26	-11.12	-5.81	-2.58	-11.46
Normalized Net Income, 3 Yr. CAGR %	-6.08	-4.28	-3.39	-9.98	-7.13
Diluted EPS Before Extra, 3 Yr. CAGR %	66.02	-6.61	-2.03	0.48	-9.74
Accounts Receivable, 3 Yr. CAGR %	11.81	10.99	11.1	17.11	11.48
Inventory, 3 Yr. CAGR %	11.16	11.6	11.21	34.72	19.64
Net Property, Plant and Equip., 3 Yr. CAGR %	2.02	5.06	3.63	7.56	7.28
Total Assets, 3 Yr. CAGR %	-7.66	-2.71	2.94	15.56	14.51
Tangible Book Value, 3 Yr. CAGR %	126.94	34.33	4.57	27.23	20.07
Common Equity, 3 Yr. CAGR %	-28.03	-18.77	-27.67	-12.83	-4.27
Cash From Operations, 3 Yr. CAGR %	-2.07	-6.41	2.04	-6.9	7.45
Capital Expenditures, 3 Yr. CAGR %	-2.89	6.04	14.84	22.29	7.59
Levered Free Cash Flow, 3 Yr. CAGR %	2.44	-1.83	10.62	-37.37	22.24
Unlevered Free Cash Flow, 3 Yr. CAGR %	1.65	-2.13	9.82	-21.23	24.65
Dividend Per Share, 3 Yr. CAGR %	11.64	10.06	10.19	10.01	8.53
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.25	2.47	2.87	3.49	7.43
Gross Profit, 5 Yr. CAGR %	1.96	0.73	1.18	0.13	3.86
EBITDA, 5 Yr. CAGR %	3.72	1.06	1.95	-0.67	5.18
EBITA, 5 Yr. CAGR %	3.87	1.05	1.71	-1.13	5.38
EBIT, 5 Yr. CAGR %	1.57	-1.03	-0.53	-5.39	-0.13
Earnings From Cont. Operations, 5 Yr. CAGR %	0.92	-5.26	27.05	-4.36	-12.21
Net Income, 5 Yr. CAGR %	0.92	-5.26	27.05	-4.36	-12.21
Normalized Net Income, 5 Yr. CAGR %	0.03	-1.03	-3.78	-9.06	-5.33
Diluted EPS Before Extra, 5 Yr. CAGR %	6.32	0.08	35.11	-0.21	-10.11
Accounts Receivable, 5 Yr. CAGR %	8.6	9.11	11.44	15.21	10.82
Inventory, 5 Yr. CAGR %	9.84	8.28	11.71	26.49	14.32
Net Property, Plant and Equip., 5 Yr. CAGR %	1.54	3	3.78	5.86	5.64
Total Assets, 5 Yr. CAGR %	-2.5	-4.65	-4.02	7.9	8.99
Tangible Book Value, 5 Yr. CAGR %	67.57	36.99	71.73	36.11	10.6
Common Equity, 5 Yr. CAGR %	-19.64	-25.84	-32.03	-13	-9.49
Cash From Operations, 5 Yr. CAGR %	1.53	-2.21	-2.75	-5.59	4.66
Capital Expenditures, 5 Yr. CAGR %	0.47	3.58	7.11	8.54	12.14
Levered Free Cash Flow, 5 Yr. CAGR %	5.53	2.46	0.8	-22.12	16.25
Unlevered Free Cash Flow, 5 Yr. CAGR %	5	2.12	0.86	-11.33	17.11
Dividend Per Share, 5 Yr. CAGR %	15.16	11.97	11.02	10.04	9.18